Study To Assess Efficacy and Safety of Oglemilast in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Public ClinicalTrials.gov record NCT00671073. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase II Dose-Ranging Study of the Efficacy and Safety of Oglemilast in Patients With COPD
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will assess the safety and efficacy of a range of oglemilast doses. The study will be 14 weeks in duration. All patients meeting the eligibility criteria will be randomized to one of three doses of oglemilast or placebo.
Study identification
- NCT ID
- NCT00671073
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 427 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 40 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 4, 2008
- Primary completion
- May 14, 2009
- Completion
- May 14, 2009
- Last update posted
- Sep 18, 2019
2008 – 2009
United States locations
- U.S. sites
- 47
- U.S. states
- 22
- U.S. cities
- 43
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Forest Investigative Site | Birmingham | Alabama | 35215 | — |
| Forest Investigative Site | Phoenix | Arizona | 85006 | — |
| Forest Investigative Site | Tucson | Arizona | 85715 | — |
| Forest Investigative Site | Buena Park | California | 90620 | — |
| Forest Investigative Site | Encinitas | California | 92024 | — |
| Forest Investigative Site | Fullerton | California | 92835 | — |
| Forest Investigative Site | Los Angeles | California | 90095 | — |
| Forest Investigative Site | Orange | California | 92868 | — |
| Forest Investigative Site | Rancho Mirage | California | 92270 | — |
| Forest Investigative Site | San Diego | California | 92120 | — |
| Forest Investigative Site | San Diego | California | 92134 | — |
| Forest Investigative Site | Stockton | California | 95207 | — |
| Forest Investigative Site | Centennial | Colorado | 80112 | — |
| Forest Investigative Site WR1 | Wheat Ridge | Colorado | 80033 | — |
| Forest Investigative Site WR2 | Wheat Ridge | Colorado | 80033 | — |
| Forest Investigative Site | Waterbury | Connecticut | 06708 | — |
| Forest Investigative Site | Fort Lauderdale | Florida | 33316 | — |
| Forest Investigative Site | Miami | Florida | 33155 | — |
| Forest Investigative Site | Miami | Florida | 33169 | — |
| Forest Investigative Site | Ormond Beach | Florida | 32174 | — |
| Forest Investigative Site | Tamarac | Florida | 33321 | — |
| Forest Investigative Site | Skokie | Illinois | 60076 | — |
| Forest Investigative Site | Evansville | Indiana | 47713 | — |
| Forest Investigative Site | North Dartmouth | Massachusetts | 02747 | — |
| Forest Investigative Site | Livonia | Michigan | 48152 | — |
| Forest Investigative Site | Edina | Minnesota | 55437 | — |
| Forest Investigative Site | Minneapolis | Minnesota | 55407 | — |
| Forest Investigative Site | Papillion | Nebraska | 68046 | — |
| Forest Investigative Site | Cherry Hill | New Jersey | 08003 | — |
| Forest Investigative Site | Elmira | New York | 14901 | — |
| Forest Investigative Site | Mineola | New York | 11501 | — |
| Forest Investigative Site | Rochester | New York | 14618 | — |
| Forest Investigative Site | Charlotte | North Carolina | 28207 | — |
| Forest Investigative Site | Cincinnati | Ohio | 45231 | — |
| Forest Investigative Site | Cincinnati | Ohio | 45242 | — |
| Forest Investigative Site | Toledo | Ohio | 43614 | — |
| Forest Investigative Site | Medford | Oregon | 97504 | — |
| Forest Investigative Site | Portland | Oregon | 97213 | — |
| Forest Investigative Site | Bethlehem | Pennsylvania | 18020 | — |
| Forest Investigative Site | Philadelphia | Pennsylvania | 19140 | — |
| Forest Investigative Site | Charleston | South Carolina | 29406 | — |
| Forest Investigative Site | Greenville | South Carolina | 29615 | — |
| Forest Investigative Site | Spartanburg | South Carolina | 29303 | — |
| Forest Investigative Site | El Paso | Texas | 79902 | — |
| Forest Investigative Site | San Antonio | Texas | 78229 | — |
| Forest Investigative Site | Fredericksburg | Virginia | 22401 | — |
| Forest Investigative Site | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Pulmonary Disease, Chronic Obstructive trials
Other public records listing Pulmonary Disease, Chronic Obstructive. Sorted by last update posted; newest first. Not a recommendation.
- NCT07759245: A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) Not yet recruiting
- NCT07177339: eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation Recruiting
- NCT07714252: Virtual Nurse and Social Worker Palliative Care Team to Improve Quality of Life in Veterans With Heart Failure or COPD Not yet recruiting
- NCT05718102: Pragmatic Trial to Enhance Quality Safety, and Patient Experience in COPD Active, not recruiting
- NCT04669743: Innate Immunity in Ozone-induced Airway Inflammation in COPD Active, not recruiting
- NCT06961214: Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2) Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00671073, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 18, 2019 · Synced Sep 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00671073 live on ClinicalTrials.gov.